Feasibility of diagnosing and staging liver fibrosis with diffusion weighted imaging

Chinese Medical Sciences Journal

Volumn 23, Issue 3, 2008, Pages 183-186

  Zhu, Nai Yi ^a   Chen, Ke Min ^a   Chai, Wei Min ^a   Li, Wei Xia ^a   Du, Lian Jun ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Apparent diffusion coefficient; Diffusion weighted imaging; Liver fibrosis

Indexed keywords

ADULT; ARTICLE; CANCER DIAGNOSIS; CANCER STAGING; CLINICAL ARTICLE; CLINICAL ASSESSMENT TOOL; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC VALUE; DIFFUSION COEFFICIENT; DIFFUSION WEIGHTED IMAGING; DISEASE SEVERITY; FEASIBILITY STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER FIBROSIS; MALE; PREDICTION; QUANTITATIVE ANALYSIS; SENSITIVITY AND SPECIFICITY;

EID: 55049106102     PISSN: 10019294     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1001-9294(09)60036-5     Document Type: Article

References (16)

1. Chevallier M, Guerret S, Chossegros P, et al. A histological semiquantitative scoring system for evaluation of hepatic fibrosis in needle liver biopsy specimens: comparison with morphometric studies. Hepatology 1994; 20:349-55.
2. Saunders JB, Walters JRF, David P, et al. A 20-year prospective study of cirrhosis. Br Med J 1981; 282:263-6.
3. Fattovich G, Giustina G, Degos F, et al. Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patients. Gastroenterology 1997; 112:463-72.
4. Ishak K, Baptista A, Bianchi L, et al. Histological grading and staging of chronic hepatitis. J Hepatology 1995; 22:696-9.
5. Afdhal NH. Diagnosing fibrosis in hepatitis C: is the pendulum swinging from biopsy to blood tests? Hepatology 2003; 37:972-4.
6. Cales P, Oberti F, Michalak S, et al. A novel panel of blood markers to presence of liver fibrosis: a cohort study. Gastroenterology 2005; 42:1373-81.
7. Rosenberg WMC, Voelker M, Thiel R, et al. Serum markers detect the presence of liver fibrosis: a cohort study. Gastroenterology 2004; 127:1704-13.
8. Taouli B, Tolia AJ, Losada, M, et al. Diffusion-weighted MRI for quantificafflon of liver fibrosis: preliminary experience. AJR Am J Roentqenlol 2007; 189:799-806.
9. Yang Y, Song B, Wu B. Relationship of megnetic resonance diffusion-weighted imaging to histology in chronic viral hepatitis. Chin J Bases Clin General Surg 2006; 13:469-73.
10. Aube C, Racineux PX, Lebigot J, et al. Diagnosis and quantification of hepatic fibrosis with diffusion weighted MR imaging: preliminary results. J Radio 2004; 85:301-6.
11. Hu XF, Liu B, Qian YF, et al. A pilot study of hepatic fibosis with magnetic resonance diffusion-weighted imaging in a rabbit model. Zhonghua Gan Zang Bing Za Zhi 2008; 16: 500-4.
12. Wang K, Wang PJ, Zhao ZH, et al. Functional MRI in chronic liver disease of hepatitis B patients. Zhonghua Gan Zang Bing Za Zhi 2006; 14:590-6.
13. Wang QS, Guo QY, Liang CH, et al. Diffusion weighted MR imaging in experiment liver fibrosis model in rabbits: preliminary study. Chin J Med Imaging Technol 2007; 23: 952-5.
14. Ichikawa T, Haradome H, Hachiya J, et al. Diffusion-weighted MR imaging with single-shot echo-planar imaging in the upper abdomen: preliminary clinical experience in 61 patients. Abdom Imaging 1999; 24:456-61.
15. Yamashita Y, Tang Y, Takahashi M. Ultrafast MR imaging of the abdomen: echo planar imaging and diffusion-weighted imaging. JMRI 1998; 8:367-74.
16. Okada Y, Ohtomo K, Kiryu S, et al. Breath-hold T2-weighted MRI of hepatic tumors: value of echo planar imaging with diffusion-sensitizing gradient. J Comput Assist Tomogr 1999; 22:364-71.